Trafalgar International (GCAN) Operating Expenses (2017 - 2026)
Trafalgar International (GCAN) posted Operating Expenses of $33376.0 for Q1 2026, down 37.97% on a QoQ basis from $53806.0 in Q4 2025, and down 23.34% year-over-year from $43536.0 in Q1 2025.
Analysis
Trafalgar International (GCAN) Operating Expenses (2017 - 2026) Analysis & Trends
Trafalgar International has reported Operating Expenses for 10 years, with the latest figure at $33376.0 in Q1 2026.
- On a quarterly basis, Operating Expenses fell 23.34% year-over-year to $33376.0 in Q1 2026; TTM through Mar 2026 was $172845.0, a 7.45% increase from a year earlier, with the FY2025 full-year figure at $183005.0, up 17.1% from the prior year.
- Operating Expenses was $33376.0 for Q1 2026 at Trafalgar International, down from $53806.0 in the prior quarter.
- The five-year high for Operating Expenses was $53806.0 in Q4 2025, with the low at $33376.0 in Q1 2026.
- Average Operating Expenses over 5 years is $42650.4, with a median of $42267.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses plunged 64.81% in 2022, then soared 43.01% in 2025.
- Over 5 years, Operating Expenses stood at $42267.0 in 2022, then rose by 4.16% to $44027.0 in 2023, then dropped by 14.54% to $37625.0 in 2024, then jumped by 43.01% to $53806.0 in 2025, then plunged by 37.97% to $33376.0 in 2026.
- The last three Operating Expenses figures came in at $33376.0 (Q1 2026), $53806.0 (Q4 2025), and $37412.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | 33,376.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 33,376.00 |
| Dec 31, 2025 | 53,806.00 |
| Sep 30, 2025 | 37,412.00 |
| Jun 30, 2025 | 48,251.00 |
| Mar 31, 2025 | 43,536.00 |
| Dec 31, 2024 | 37,625.00 |
| Sep 30, 2024 | 40,443.00 |
| Jun 30, 2024 | 39,257.00 |
| Mar 31, 2024 | 38,951.00 |
| Dec 31, 2023 | 44,027.00 |
| Sep 30, 2023 | 50,465.00 |
| Jun 30, 2023 | 41,404.00 |
| Mar 31, 2023 | 39,468.00 |
| Dec 31, 2022 | 42,267.00 |
| Sep 30, 2022 | 49,304.00 |
| Jun 30, 2022 | 43,034.00 |
| Mar 31, 2022 | 42,430.00 |
| Dec 31, 2021 | 120,102.00 |
| Sep 30, 2021 | 74,338.00 |
| Jun 30, 2021 | 62,449.00 |